# BRIEFING — 2026-09-21T04:53:00Z

## Mission
Review test suite health, regression immunity, and CI configuration for Milestone 3 (Backend Reliability & Automated Test Pass) and issue verdict.

## 🔒 My Identity
- Archetype: teamwork_preview_reviewer_m3_2
- Roles: reviewer, critic
- Working directory: /home/finn-powers/Sigma/.agents/teamwork_preview_reviewer_m3_2
- Original parent: 577e7284-a2c1-4701-a8c5-e2273d49b529
- Milestone: M3 (Backend Reliability & CI Test Health)
- Instance: 2 of 2

## 🔒 Key Constraints
- Review-only — do NOT modify implementation code
- Report findings rather than fixing them
- Actively check for integrity violations (hardcoded test results, facade implementations, bypassed tasks, fabricated outputs)

## Current Parent
- Conversation ID: 577e7284-a2c1-4701-a8c5-e2273d49b529
- Updated: 2026-09-21T04:53:00Z

## Review Scope
- **Files to review**: `pytest.ini`, `tests/conftest.py`, `app/core/duckdb_store.py`, `app/server/main.py`, `app/execution/LoopAPipeline.py`, `app/server/routes_sigma.py`, `app/execution/reliable_order_dispatcher.py`, test files
- **Interface contracts**: PROJECT.md, ORIGINAL_REQUEST.md
- **Review criteria**: test suite health, regression immunity, CI configuration, direct pytest invocation, sandbox isolation, integrity checking

## Review Checklist
- **Items reviewed**: [In progress]
- **Verdict**: Pending
- **Unverified claims**: pytest.ini direct invocation, conftest.py isolation, full test pass, integrity of fixes

## Attack Surface
- **Hypotheses tested**: [TBD]
- **Vulnerabilities found**: [TBD]
- **Untested angles**: [TBD]

## Key Decisions Made
- Initial assessment started; reviewing pytest.ini, tests/conftest.py, git diff, and executing pytest -q.

## Artifact Index
- /home/finn-powers/Sigma/.agents/teamwork_preview_reviewer_m3_2/DISPATCH.md
- /home/finn-powers/Sigma/.agents/teamwork_preview_reviewer_m3_2/BRIEFING.md
- /home/finn-powers/Sigma/.agents/teamwork_preview_reviewer_m3_2/report.md
- /home/finn-powers/Sigma/.agents/teamwork_preview_reviewer_m3_2/handoff.md
